» Articles » PMID: 27312972

Early Synaptic Deficits in the APP/PS1 Mouse Model of Alzheimer's Disease Involve Neuronal Adenosine A2A Receptors

Abstract

Synaptic plasticity in the autoassociative network of recurrent connections among hippocampal CA3 pyramidal cells is thought to enable the storage of episodic memory. Impaired episodic memory is an early manifestation of cognitive deficits in Alzheimer's disease (AD). In the APP/PS1 mouse model of AD amyloidosis, we show that associative long-term synaptic potentiation (LTP) is abolished in CA3 pyramidal cells at an early stage. This is caused by activation of upregulated neuronal adenosine A2A receptors (A2AR) rather than by dysregulation of NMDAR signalling or altered dendritic spine morphology. Neutralization of A2AR by acute pharmacological inhibition, or downregulation driven by shRNA interference in a single postsynaptic neuron restore associative CA3 LTP. Accordingly, treatment with A2AR antagonists reverts one-trial memory deficits. These results provide mechanistic support to encourage testing the therapeutic efficacy of A2AR antagonists in early AD patients.

Citing Articles

Distinct disruptions in CA1 and CA3 place cell function in Alzheimer's disease mice.

Park S, Park M, Kim E, Kim J, Cho J, Huh Y iScience. 2025; 28(2):111631.

PMID: 39911347 PMC: 11795144. DOI: 10.1016/j.isci.2024.111631.


Blockade of AR improved brain perfusion and cognitive function in a mouse model of Alzheimer's disease.

Udo M, Zaccarelli-Magalhaes J, Clemons G, Citadin C, Langman J, Smith D Geroscience. 2025; .

PMID: 39843732 DOI: 10.1007/s11357-025-01526-8.


Enhanced prefrontal nicotinic signaling as evidence of active compensation in Alzheimer's disease models.

Power S, Venkatesan S, Qu S, McLaurin J, Lambe E Transl Neurodegener. 2024; 13(1):58.

PMID: 39623428 PMC: 11613856. DOI: 10.1186/s40035-024-00452-7.


Paraxanthine enhances memory and neuroplasticity more than caffeine in rats.

Jager R, Abou Sawan S, Orru M, Tinsley G, Purpura M, Wells S Exp Brain Res. 2024; 243(1):8.

PMID: 39617850 PMC: 11609120. DOI: 10.1007/s00221-024-06954-0.


Navigating Alzheimer's Disease Mouse Models: Age-Related Pathology and Cognitive Deficits.

De Plano L, Saitta A, Oddo S, Caccamo A Biomolecules. 2024; 14(11).

PMID: 39595581 PMC: 11592094. DOI: 10.3390/biom14111405.


References
1.
Kesner R . A process analysis of the CA3 subregion of the hippocampus. Front Cell Neurosci. 2013; 7:78. PMC: 3664330. DOI: 10.3389/fncel.2013.00078. View

2.
Paoletti P, Bellone C, Zhou Q . NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci. 2013; 14(6):383-400. DOI: 10.1038/nrn3504. View

3.
Malinow R . New developments on the role of NMDA receptors in Alzheimer's disease. Curr Opin Neurobiol. 2011; 22(3):559-63. PMC: 3405538. DOI: 10.1016/j.conb.2011.09.001. View

4.
Kaster M, Machado N, Silva H, Nunes A, Ardais A, Santana M . Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proc Natl Acad Sci U S A. 2015; 112(25):7833-8. PMC: 4485143. DOI: 10.1073/pnas.1423088112. View

5.
Hanson J, Pare J, Deng L, Smith Y, Zhou Q . Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease. Neurobiol Dis. 2014; 74:254-62. PMC: 4419865. DOI: 10.1016/j.nbd.2014.11.017. View